Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T‐cell lymphoma, nasal type-Reference-Cited by-同舟云学术

Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T‐cell lymphoma, nasal type

Published:2019-12 Issue:1 Volume:38 Page:103-105
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Zheng Yingjuan¹,Yang Chunzhao¹,Liang Tiansong¹,Yang Daoke¹^ORCID,Liu Zhangsuo²

Affiliation:

1. Department of RadiotherapyThe First Affiliated Hospital of Zhengzhou University Zhengzhou Henan People's Republic of China

2. Department of Blood PurificationThe First Affiliated Hospital and Institute of Nephrology, Zhengzhou University Zhengzhou Henan People's Republic of China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2637

Reference10 articles.

1. Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study

2. The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis

3. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

4. A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

5. First-line combination of GELOX followed by radiation therapy for patients with stage IE/IIE ENKTL: An updated analysis with long-term follow-up

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extranodal Natural Killer/T-cell Lymphoma Isolated to the Leg: A Case Report;Cureus;2023-06-05

2. Comparison of chemotherapy with or without asparaginase for extranodal nasal NK/T‐cell lymphoma in children and adolescents;Pediatric Blood & Cancer;2021-01-23